[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-353239-105":59,"doc-detail-353239-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","inhibiting-fatty-acid-oxidation-reverses-autophagy-mediated-acquired-chemotherapy-resistance-in-pancreatic-ductal-adenocarcinoma","Inhibiting Fatty Acid Oxidation Reverses Autophagy-Mediated Acquired Chemotherapy Resistance in Pancreatic Ductal Adenocarcinoma","","Pancreatic ductal adenocarcinoma driven relapse after chemotherapy is sustained by autophagy-linked acquired drug resistance. Irinotecan induces a dual-phase autophagy program in which early DNA-damage signaling activates AMPK and fuels fatty acid oxidation to raise ATP, followed later by ATP-mediated AMPK inactivation and mTOR activation. Despite this, autophagy and fatty acid oxidation persist via a JNK1–Beclin-1 pathway, yielding paradoxical coactivation that promotes survival. Inhibition of fatty acid oxidation, including KN510713 use or FAO gene knockdown, blocks autophagy flux and cell growth, impairing flux through fatty acid accumulation. Combined therapy with irinotecan and FAO inhibition prevents xenograft regrowth, suggesting a strategy to reverse acquired resistance while limiting toxicity from systemic autophagy blockade.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/inhibiting-fatty-acid-oxidation-reverses-autophagy-mediated-acquired-chemotherapy-resistance-in-pancreatic-ductal-adenocarcinoma/353239/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/inhibiting-fatty-acid-oxidation-reverses-autophagy-mediated-acquired-chemotherapy-resistance-in-pancreatic-ductal-adenocarcinoma/353239.png","ImageObject",300,407,{"name":92,"@type":93},"Blitz","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-28","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What problem does the study address in pancreatic cancer treatment?","Question",{"text":112,"@type":113},"It addresses how pancreatic ductal adenocarcinoma can relapse after chemotherapy by developing acquired drug resistance, even when patients initially respond.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How does irinotecan influence autophagy in the described model?",{"text":117,"@type":113},"Irinotecan triggers a dual-phase autophagy process that initially depends on AMPK and later involves ATP-driven mTOR activation, while autophagy can still persist through additional signaling.",{"name":119,"@type":110,"acceptedAnswer":120},"How does fatty acid oxidation inhibition affect chemotherapy resistance?",{"text":121,"@type":113},"Combining irinotecan with fatty acid oxidation inhibition using KN510713 or knocking down FAO blocks autophagy flux, suppresses cell growth, induces cytotoxicity, and reduces tumor regrowth in xenograft models.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},353239,1790151452,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":56,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},24464137899374,"https://us-avatar.wpscdn.com/davatar_3d24733baf745e90a7e4bdd5f77d97b2","Inhibiting Fatty Acid Oxidation Reverses  \nAutophagy-Mediated Acquired Chemotherapy Resistance in Pancreatic Ductal Adenocarcinoma  \nSang Myung Woo1,2,3, Joon Hee Kang2,4, Wonyoung Choi2,5,6, Ho Lee2,5, Hyonchol Jang2,5,  \nSung Hoon Sim6, Jung Won Chun1,2,3, Eun-Byeol Koh5, Chaeyoung Kim4,5, Woojin Ham4,5, Woosol Hong4,5, Mingyu Kang4,5, JeongHwan Park4,5, Suji Han2,5, Jong Woo Kim7, Eun-Woo Lee7,8,9, Woo Jin Lee1,3, and Soo-Youl Kim4,5  \n|  |  | A |  | B | S |  | T | R |  | A |  | C | T |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |\n|  | In pancreatic ductal adenocarcinoma (PDAC), irinotecan (1μmol/L) chemotherapy triggers a dual-phase autophagy process that drives drug resistance. Although mTOR and autophagy exert suppressive effects on each other, coactivation of mTOR and autophagy has been observed when PDAC cells begin to regrow after treatment. Therefore, we hypothesized that the distinct temporal phases of autophagy are governed by independent upstream pathways. Initially, DNA damage activated AMPK, inducing early autophagy within 24 hours that fueled fatty acid oxidation (FAO), boosting ATP production. After 48 hours, elevated ATP levels inactivated AMPK and activated mTOR, which typically suppresses autophagy. However, autophagy and FAO activity persisted beyond 72 hours of irinotecan treatment via the JNK1–Beclin-1 pathway. This created a paradoxical state in which mTOR and autophagy were coactivated, promoting cell survival under irinotecan treatment. Irinotecan combined with FAO inhibition using KN510713 (a combination of KN510 targeting the carnitine–acylcarnitine transporter and KN713 targeting acetylCoA acyltransferase1/2) or FAO gene knockdown blocked autophagy flux and cell growth. FAO inhibition–induced fatty acid accumulation impaired autophagy flux and induced cytotoxicity, leading to cancer cell death. In xenograft models, combining irinotecan with KN510713 significantly prevented tumor regrowth compared with irinotecan alone. These findings suggest that targeting FAO induced by autophagy activation may overcome acquired drug resistance in PDAC while minimizing the toxic side effects associated with systemic inhibition of autophagy in healthy cells.\u003Cbr>􀀶 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | Significance: Combined treatment with irinotecan and fatty acid oxidation inhibition reverses acquired drug resistance driven by autophagy in pancreatic cancer.\u003Cbr>\u003Cbr>ATP\u003Cbr>0\u003Cbr>AMPK Anticancer drug\u003Cbr>FAO\u003Cbr>ATP\u003Cbr>100\u003Cbr>mTOR\u003Cbr>AMPK-autophagy\u003Cbr>JNK\u003Cbr>JNK-autophagy\u003Cbr>Acquired drug resistance |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |\n\nIntroduction  \nThe main issue with cancer treatment is that tumors often grow back and become resistant to therapy in patients who initially respond well to chemotherapy. This phenomenon is known clinically  \n1Research Institute, National Cancer Center, Goyang, Republic of Korea. 2Department of Cancer Biomedical Science, National Cancer Center Graduate School of Cancer Sci","cbCaivJd9wq4s2Wf","https://ap.wps.com/l/cbCaivJd9wq4s2Wf","pdf",28041130,"English","# Introduction\n## Acquired chemotherapy resistance and relapse\n## Autophagy involvement in drug resistance","[{\"question\":\"What problem does the study address in pancreatic cancer treatment?\",\"answer\":\"It addresses how pancreatic ductal adenocarcinoma can relapse after chemotherapy by developing acquired drug resistance, even when patients initially respond.\"},{\"question\":\"How does irinotecan influence autophagy in the described model?\",\"answer\":\"Irinotecan triggers a dual-phase autophagy process that initially depends on AMPK and later involves ATP-driven mTOR activation, while autophagy can still persist through additional signaling.\"},{\"question\":\"How does fatty acid oxidation inhibition affect chemotherapy resistance?\",\"answer\":\"Combining irinotecan with fatty acid oxidation inhibition using KN510713 or knocking down FAO blocks autophagy flux, suppresses cell growth, induces cytotoxicity, and reduces tumor regrowth in xenograft models.\"}]","Inhibiting Fatty Acid Oxidation Reverses Autophagy-Mediated Acquired Chemotherapy Resistance in Pancreatic Ductal Adenocarcinoma | PDF",1790103801,48,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8469518abf40ad836c6a10589000af9b.webp",983,1315,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b360054a3ef7667d4cf53bd3668d6df0.webp",982,1314,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/928b00b2ee5aa3c36cc104c29ed6a500.webp",981,1312,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e2a44c4452d7fa99a972b7528e9e55d5.webp",980,1311]